QUANTITATION OF COAGULATION INHIBITION IN-VIVO DUE TO BREAKDOWN PRODUCTS OF FIBRIN

被引：0
作者：
MITCHELL, PS
BELLER, FK
机构：
来源：
THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1970年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：477 / &
相关论文
共 21 条
[1]  
ASTRUP T, IN PRESS
[2]  
BANG NU, 1963, THROMBOS DIATHES S13, P131
[3]   PROPERTIES OF FIBRINOGENOLYSIS AND FIBRINOLYSIS PRODUCTS IN IMMUNE ASSAYS [J].
BELLER, FK ;
MAKI, M .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1967, 18 (1-2) :114-&
[4]  
FLETCHE.AP, 1966, J LAB CLIN MED, V68, P780
[5]   PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J].
FLETCHER, AP ;
SHERRY, S ;
ALKJAERSIG, N .
JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :896-&
[6]   INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON LAST STAGE OF COAGULATION [J].
GODAL, HC ;
HELLE, I .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1963, 15 (04) :327-&
[7]  
HILL B, 1961, PRINCIPLES MEDICAL S
[8]  
LARRIEU MJ, 1966, T C INT COMM HEMOSTA
[9]  
LEWIS JH, 1965, AM J PHYSIOL, V209, P1053
[10]  
MANCINI G, 1965, LAB SYNOPSIS, V1, P43
123